Neutral
This article, "The Escalator," details recent personnel changes and key events across the pharma, biotech, and medical marketing industries. It highli...
Bearish
Japanese drugmaker Kissei Pharmaceutical announced that doctors in Japan can resume prescribing Amgen's rare-disease drug, Tavneos, to new patients, r...
Neutral
Amgen's CFO, Peter Griffith, is retiring after six years, and Thomas Dittrich has been named as his successor. Dittrich, who previously served as CFO ...
Amgen's current CFO, Peter Griffith, is set to retire by early next year and will be replaced by Thomas Dittrich, formerly of Galderma, starting Septe...
Bullish
Atle Fund Management AB significantly increased its stake in Amgen Inc. by 58.6% in the fourth quarter, now holding 21,903 shares valued at approximat...
Neutral
Amgen (US0311621009) is drawing investor attention with new data on its experimental obesity treatment, MariTide, and progress across its broad biotec...
Bullish
Amgen Inc. is currently in the spotlight due to new data on its experimental obesity drug and its recent quarterly report. The company's strategy focu...
Neutral
Resona Asset Management Co. Ltd. reduced its stake in Amgen Inc. by 3.3% in the fourth quarter, selling 5,981 shares. Despite this trim, their holding...
Bullish
Profund Advisors LLC increased its stake in Amgen Inc. by 11% in the fourth quarter, bringing its total holdings to 62,287 shares valued at $20.4 mill...
Neutral
Amgen (AMGN) stock presents an interesting investment case due to its reasonable growth, strong cash flow, low debt, and relatively cheap valuation. T...
This article discusses uncontrolled gout, a severe form of the common disease affecting a small fraction of gout patients. It highlights how the condi...
Bearish
Amgen Inc.'s ChemoCentryx Inc. has agreed to pay $69 million to settle an investor class action lawsuit. Investors alleged that the company overstated...
Neutral
Amgen Inc. (AMGN) reported strong Q1 2026 earnings driven by a 34% surge in Repatha sales and 25% growth in its rare disease portfolio. However, the c...
Bullish
The North Dakota State Investment Board has acquired a new position in Amgen Inc. (NASDAQ:AMGN) during the fourth quarter, purchasing 18,823 shares va...
Bullish
GLOBALT Investments LLC GA increased its stake in Amgen Inc. by 25.4% in the fourth quarter, now holding 25,923 shares valued at approximately $8.49 m...
Bullish
Leuthold Group LLC increased its stake in Amgen Inc. by 25.8% in the fourth quarter, purchasing 4,396 additional shares to reach a total of 21,402 sha...
Bullish
L & S Advisors Inc has acquired a new stake in Amgen Inc. (NASDAQ:AMGN) during the fourth quarter, purchasing 13,104 shares valued at approximately $4...
Bullish
iA Global Asset Management Inc. has increased its stake in Amgen Inc. by 7.4% in the fourth quarter, bringing its total holdings to 66,947 shares valu...
Neutral
STF Management LP significantly reduced its stake in Amgen Inc. by selling 5,198 shares, cutting its holdings by 64.7% to 2,831 shares valued at $927,...
Neutral
Northwestern Mutual Wealth Management Co. significantly increased its stake in Amgen Inc. by 596.5% during the fourth quarter, purchasing 323,064 addi...